| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.28 | 6e-07 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.33 | 3e-06 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.16 | 8e-06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.24 | 1e-05 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.29 | 3e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |